Adlai Nortye Ltd. American Depositary Shares (ANL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $9.19
• Market Cap: $358.30M
• EPS: $-1.14
• 52-Week High: $12.09
• 52-Week Low: $0.88

Market Sentiment

Adlai Nortye Ltd. American Depositary Shares currently has a Bullish sentiment score of 0.62.

About Adlai Nortye Ltd. American Depositary Shares

Adlai Nortye Ltd. is a clinical-stage biotechnology company focused on the research and development of innovative cancer therapies, primarily targeting opportunities in the United States and Mainland China. Headquartered in Grand Cayman, the firm is committed to leveraging cutting-edge scientific methodologies to meet significant unmet medical needs in oncology. With a strong and diverse pipeline, Adlai Nortye is strategically positioned to make a meaningful impact in the cancer treatment lan...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Adlai Nortye Ltd. American Depositary Shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ANL pay dividends?

Adlai Nortye Ltd. American Depositary Shares (ANL) does not currently pay a regular dividend.

What is ANL's market cap?

Adlai Nortye Ltd. American Depositary Shares (ANL) has a market capitalization of $358.30M with a current stock price of $9.19.